{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:58:09Z","timestamp":1781233089999,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10517-026-06690-1","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:12:04Z","timestamp":1780416724000},"page":"631-637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GRO\u2011\u03b1 Promotes the Proliferation and Migration of Triple-Negative Breast Cancer Cells through AKT-mTOR Signaling Pathway"],"prefix":"10.1007","volume":"180","author":[{"given":"Shengyang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"6","key":"6690_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin."},{"issue":"10","key":"6690_CR2","first-page":"2929","volume":"5","author":"X Dai","year":"2015","unstructured":"Dai X, Li T, Bai Z, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015;5(10):2929.","journal-title":"Am J Cancer Res."},{"issue":"1","key":"6690_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.22381","volume":"109","author":"EA Rakha","year":"2007","unstructured":"Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109(1):25-32. https:\/\/doi.org\/10.1002\/cncr.22381","journal-title":"Cancer."},{"issue":"6","key":"6690_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD, Jovanovi\u0107 B, Chen X, et al. Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS One. 2016;11(6):e0157368. https:\/\/doi.org\/10.1371\/journal.pone.0157368","journal-title":"PLoS One."},{"issue":"19","key":"6690_CR5","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.1073\/pnas.87.19.7732","volume":"87","author":"S Haskill","year":"1990","unstructured":"Haskill S, Peace A, Morris J, et al. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci. 1990;87(19):7732-6. https:\/\/doi.org\/10.1073\/pnas.87.19.7732","journal-title":"Proc Natl Acad Sci."},{"issue":"5","key":"6690_CR6","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1074\/jbc.M006115200","volume":"276","author":"D Wang","year":"2001","unstructured":"Wang D, Richmond A. Nuclear factor-\u03baB activation by the CXC chemokine melanoma growth-stimulatory activity\/ growth-regulated protein involves the MEKK1\/p38 mitogen-activated protein kinase pathway. J Biol Chem. 2001;276(5):3650-9. https:\/\/doi.org\/10.1074\/jbc.M006115200","journal-title":"J Biol Chem."},{"issue":"8","key":"6690_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072744","volume":"8","author":"K Zhang","year":"2013","unstructured":"Zhang K, Tian L, Liu L, et al. CXCL1 contributes to \u03b2-amyloid-induced transendothelial migration of monocytes in Alzheimer\u2019s disease. PloS One. 2013;8(8):e72744. https:\/\/doi.org\/10.1371\/journal.pone.0072744","journal-title":"PloS One."},{"issue":"7","key":"6690_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/labinvest.2013.71","volume":"93","author":"M Miyake","year":"2013","unstructured":"Miyake M, Goodison S, Urquidi V, et al. Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1\/2 and EGF pathways. Lab Invest. 2013;93(7):768-78. https:\/\/doi.org\/10.1038\/labinvest.2013.71","journal-title":"Lab Invest."},{"issue":"2","key":"6690_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/cancers12020287","volume":"12","author":"HTT Do","year":"2020","unstructured":"Do HTT, Lee CH, Cho J. Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers. Cancers. 2020;12(2):287. https:\/\/doi.org\/10.3390\/cancers12020287","journal-title":"Cancers."},{"key":"6690_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-014-0086-8","volume":"14","author":"Z Cao","year":"2014","unstructured":"Cao Z, Fu B, Deng B, et al. Overexpression of chemokine (CXC) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma. Cancer Cell Int. 2014;14:1-7. https:\/\/doi.org\/10.1186\/s12935-014-0086-8","journal-title":"Cancer Cell Int."},{"issue":"1","key":"6690_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13062-022-00348-4","volume":"17","author":"C Zhuo","year":"2022","unstructured":"Zhuo C, Ruan Q, Zhao X, et al. CXCL1 promotes colon cancer progression through activation of NF-\u03baB\/P300 signaling pathway. Biol Direct. 2022;17(1):34. https:\/\/doi.org\/10.1186\/s13062-022-00348-4","journal-title":"Biol Direct."},{"issue":"9","key":"6690_CR12","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1158\/1078-0432.CCR-18-3684","volume":"25","author":"R Ogawa","year":"2019","unstructured":"Ogawa R, Yamamoto T, Hirai H, et al. Loss of SMAD4 promotes colorectal cancer progression by recruiting tumor-associated neutrophils via the CXCL1\/8-CXCR2 axis. Clin Cancer Res. 2019;25(9):2887-99. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3684","journal-title":"Clin Cancer Res."},{"issue":"5","key":"6690_CR13","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1002\/jcp.29353","volume":"235","author":"YL Qi","year":"2020","unstructured":"Qi YL, Li Y, Man XX, et al. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK\/ERK pathway. J Cell Physiol. 2020;235(5):4756-65. https:\/\/doi.org\/10.1002\/jcp.29353","journal-title":"J Cell Physiol."},{"key":"6690_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-13-322","volume":"13","author":"M Miyake","year":"2013","unstructured":"Miyake M, Lawton A, Goodison S, et al. Chemokine (CXC) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers. BMC Cancer. 2013;13:1-7. https:\/\/doi.org\/10.1186\/1471-2407-13-322","journal-title":"BMC Cancer."},{"issue":"1","key":"6690_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1186\/s12885-022-09749-0","volume":"22","author":"X Man","year":"2022","unstructured":"Man X, Yang X, Wei Z, et al. High expression level of CXCL1\/GRO\u03b1 is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes. BMC Cancer. 2022;22(1):712. https:\/\/doi.org\/10.1186\/s12885-022-09749-0","journal-title":"BMC Cancer."},{"issue":"6","key":"6690_CR16","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3892\/ijo.2015.3203","volume":"47","author":"KQ Han","year":"2015","unstructured":"Han KQ, He XQ, Ma MY, et al. Targeted silencing of CXCL1 by siRNA inhibits tumor growth and apoptosis in hepatocellular carcinoma. Int J Oncol. 2015;47(6):2131-40. https:\/\/doi.org\/10.3892\/ijo.2015.3203","journal-title":"Int J Oncol."},{"issue":"1","key":"6690_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","volume":"150","author":"S Acharyya","year":"2012","unstructured":"Acharyya S, Oskarsson T, Vanharanta S, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150(1):165-78. https:\/\/doi.org\/10.1016\/j.cell.2012.04.042","journal-title":"Cell."},{"issue":"9","key":"6690_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41419-018-0876-3","volume":"9","author":"N Wang","year":"2018","unstructured":"Wang N, Liu W, Zheng Y, et al. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-\u03baB\/SOX4 signaling. Cell Death Dis. 2018;9(9):880. https:\/\/doi.org\/10.1038\/s41419-018-0876-3","journal-title":"Cell Death Dis."},{"issue":"20","key":"6690_CR19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.21037\/atm.2019.09.164","volume":"7","author":"Z Wen","year":"2019","unstructured":"Wen Z, Liu Q, Wu J, et al. Fibroblast activation protein \u03b1-positive pancreatic stellate cells promote the migration and invasion of pancreatic cancer by CXCL1-mediated Akt phosphorylation. Ann Transl Med. 2019;7(20):732. https:\/\/doi.org\/10.21037\/atm.2019.09.164","journal-title":"Ann Transl Med."},{"key":"6690_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.11.025","volume":"58","author":"L Ba","year":"2019","unstructured":"Ba L, Gao J, Chen Y, et al. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K\/Akt\/mTOR and MAPK\/ERK\/mTOR signaling pathways. Phytomedicine. 2019;58:152765. https:\/\/doi.org\/10.1016\/j.phymed.2018.11.025","journal-title":"Phytomedicine."},{"issue":"11","key":"6690_CR21","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.21037\/tcr-20-1963","volume":"9","author":"J Qian","year":"2020","unstructured":"Qian J, Cao Y, Zhang J, et al. Tanshinone IIA induces autophagy in colon cancer cells through MEK\/ERK\/mTOR pathway. Transl Cancer Res. 2020;9(11):6919. https:\/\/doi.org\/10.21037\/tcr-20-1963","journal-title":"Transl Cancer Res."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-026-06690-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-026-06690-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:49:50Z","timestamp":1781232590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-026-06690-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6690"],"URL":"https:\/\/doi.org\/10.1007\/s10517-026-06690-1","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}